dr. ellis considers the use of biosimilars in oncology
Published 5 years ago • 57 plays • Length 1:00Download video MP4
Download video MP3
Similar videos
-
1:22
dr. ellis on the entrance of biosimilars into the field of oncology
-
0:20
copy of dr. ellis on the entrance of biosimilars into the field of oncology
-
0:55
dr. weise discusses the value of biosimilars in oncology
-
0:44
dr. hamilton on the impact of biosimilars in oncology
-
1:16
dr. weise discusses the future of biosimilars in oncology
-
43:05
michelle weise | preparing for the lifelong learner
-
4:12
the basics of biosimilars
-
12:51
the enigma of biotin interference
-
0:57
dr. somer on the expansion of biosimilars in oncology
-
1:30
dr. mcbride on the potential impact of bevacizumab biosimilars in oncology
-
1:17
dr. mcbride on the emergence of biosimilars in oncology
-
1:45
dr. weise discusses challenges with biosimilar acceptance in oncology
-
1:42
dr. verma discusses challenges with biosimilars in oncology
-
1:32
dr. ellis discusses genome forward breast cancer treatment
-
1:39
dr. ellis on abemaciclib in hr-positive breast cancer
-
1:17
dr. lyman on educating physicians about biosimilars in oncology
-
1:12
dr. matthew ellis on heterogeneity impacting biomarker efficacy
-
1:44
dr. schmid on challenges concerning biosimilars in oncology
-
1:56
dr. schwartzberg on the use of therapeutic biosimilars in breast cancer
-
0:22
copy of dr. ellis on abemaciclib in hr-positive breast cancer
-
2:09
dr. esteva on the future of biosimilars in breast cancer
-
0:55
dr. ellis on measuring endocrine therapy efficacy with ki67